The lineage affinity of 57 cases of acute unclassified leukemias (AUL) was reevaluated by ultrastructural analysis of peroxidase expression (POEM) in combination with immunophenotyping and analysis of immunoglobulin gene configuration. Twenty-three cases of myeloid and three cases of megakaryocytic differentiation were identified by detection of ultrastructural myeloperoxidase (UMPO) and platelet peroxidase (UPPO). No significant correlation was noted between myeloid marker expression and POEM positivity, whereas presence of CD 19 or CD 24 antigen significantly correlated with POEM negativity (P = .001 and .023, respectively). Ig gene rearrangements including oligoclonal patterns were also recorded in 8 of 14 UMPO' patients tested. Fourteen UMPO+ patients responded poorly t o an ALL/AUL chemotherapy regimen with a low complete remission (CR)
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UBSTANTIAL PROGRESS in immunodiagnosis and
S in molecular techniques detecting immunoglobulin and T-cell antigen receptor gene rearrangements have now made it possible to classify most cases of acute leukemia as myeloid-or lymphoid-derived neoplasms. Despite these methods, the lineage affiliation of a certain subgroup of acute leukemias remains ambiguous.''2 Referred to as acute unclassified leukemias (AUL) or null-AL(L), they are usually characterized by the absence of the T-cell antigens CD1, CD2, CD5, as well as of the common ALL antigen (CALLA, CDlO), cytoplasmic or surface immunoglobulins, and of myeloperoxidase as detected by light micro~copy.'-~ AUL comprises a heterogenous group of acute leukemias including cases with myeloid, early T-or B-lymphoid surface markers, or coexpression of different lineage specificitie~.~.~.~ More recent data indicate that some of these cases are very early T-cell-or B-cell-derived leukemias.'"
The appropriate treatment strategy for AUL patients remains controversial because of the difficulty associated with the lineage classification of the disease.'.l' One large series of AUL patients treated with an ALL chemotherapy protocol showed an inferior outcome as compared with patients with CALLA' or T-cell ALL to the extent that the null-AL(L) phenotype represented an independent ad\ erse prognostic f a~t o r .~ These data raise the question of whether the inferior outcome observed in these patients resulted from the "progenitorlike" character of the leukemias or their association with the myeloid We wished to reevaluate the lineage affinity of 57 AUL patients by combining immunophenotyping and analyses of the Ig gene rearrangement with ultrastructural analysis of peroxidase expression (POEM). The latter technique identifies early myeloperoxidase (UMPO) or platelet peroxidase (UPPO) expression not detectable by light microscopy.lS-" POEM expression was then correlated with immunophenotype and genotype and the clinical outcome of UMPO-positive patients was compared with that of UMPO-negative patients.
rate of 29% and a short median remission duration (MRD) of 5 months. The POEM-patients proved very heterogenous with respect t o immunophenotype and Ig gene rearrangement. Seventeen of 21 patients tested had Ig gene rearrangements, including oligoclonal patterns. Combined data suggest that a proportion of these cases probably derive from a very immature lymphoid progenitor cell, particularly because 15 POEM-AUL patients showed a response t o ALL/AUL chemotherapy comparable t o that observed in patients with definitive acute lymphoblastic leukemia (ALL) (CR rate 80%.
MRD 20 months). Thus, ultrastructural analysis of peroxidase expression can provide decisive prognostic information in AUL patients.
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PATIENTS AND METHODS
Fifty-seven cases of newly diagnosed acute leukemia were selected according to AUL criteria of the German multicenter trial for treatment of ALL and AUL. 4 The criteria included (a) absence of morphologic and cytochemical evidence for myeloid differentiation detectable by light microscopy; and (b) absence of CD1, CD2, CD5, and CDlO antigens and negative for cytoplasmic or surface immunoglobulins.
After informed consent was obtained from all patients, pretreatment leukemic blast cells were isolated from peripheral blood (PB) or bone marrow (BM) by separation on a FicollHypaque gradient (1.077 g/mL). If the cells were not used immediately after separation, they were cryopreserved in 10% dimethylsulfoxide (DMSO) at -196°C in liquid nitrogen.
The morphologic diagnosis was based on MayGriinwald-Giemsa and cytochemical staining of BM and blood smears, including periodic acid-Schiff (PAS), peroxidase, naphthylacetate esterase, and acid phosphatase. The cases were classified according to the French-American-British (FAB) criteria."
Phenotypic analysis of the blasts was made with a broad panel of well-defined monoclonal antibodies (MoAbs) as previously de~cribed.'~ Cells.
Morphology.
Immunophenotyping. DNA analyses. High-molecular-weight (mol wt) DNA was extracted from mononuclear cells after Ficoll-Hypaque centrifugation by standard techniques, digested with appropriate restriction enzymes, electrophoresed, blotted, and hybridized to JH, C-K and c-A sequences as described elsewhere?
Transmisswn electronmicroscopy cytochemisty. For ultrastructural analysis of peroxidase activity, the method of Roels et al was used?' Fresh or liquid nitrogen-stored blasts were incubated unfixed in a medium of 20 mg diaminobenzidine (DAB, Sigma, St Louis, Mo) dissolved in 10 mL 0.05 mol/L Ringer's-Tris buffer containing H,O, at a final concentration of 0.003% for 1 h at room temperature in the dark (pH 7.4). In control experiments, either DAB or H,O, was omitted. After incubation, cells were washed and processed for electronmicroscopy as previously described?' Sections were viewed unstained or stained by Reynold's lead citrate using a Zeiss electronmicroscope (EM 10). Two hundred cells were evaluated in each case. In certain cases, the method of Graham and Karnovsky, specific for UMPO, was also applied to discriminate between UMPO and UPP0.22 For this purpose, cells were incubated in the DAB medium after fixation in 2.5% glutaraldehyde in phosphate-buffered saline (PBS). The cells were then processed as described above. In control experiments, peroxidase expression was analyzed on the same blasts before and after cryopreservation using both methods.
Treatment.
In a retrospective analysis, clinical outcome was evaluable in 29 of 57 AUL patients who received identical therapy designed for ALL and AUL in adults! The remaining 28 patients had to be excluded because of age (x < 15, x > 65; n = ll), severe disease before onset of treatment (n = 4), seconday leukemias (n = 2), diagnosis of acute megakaryoblastic leukemia by ultrastructural analysis (n = 3) or alternative treatment protocols (n = 8).
The induction therapy comprised eight cytostatic drugs administered sequentially in two phases in 8 weeks. During the fist 4
weeks, the patients received prednisone, vincristine, daunorubicin and L-asparaginase; in the second 4 weeks, they received Ara-C, cyclophosphamide, and 6-mercaptopurine. The drugs administered during reinduction therapy were dexamethasone, vincristine, and doxorubicin during the first 4 weeks and cyclophosphamide, h a -C , and thioguanine during the next 2-weeks. The rate of complete remission (CR), the survival time, and the duration of remission were measured as previously described? The closing date for statistical evaluation was November 30.1988.
Evaluation.

RESULTS
Patient charactektics. Fifty-seven patients ranging in
age from 3 months to 75 years with newly diagnosed AL For
org From
were included in the present study. Morphologic and cytochemical features of myeloid differentiation wcre not detectable in any patient. The blasts displayed either L1 or L2 morphology according to the FAB criteria. Blockpositivc PAS rcactivity was found in 39 of 57 patients. The blasts of three patients had a positive reaction for acid phosphatasc (patients 13, 14. and 33).
In 26 of 57 patients, at least 10% of the PB blasts or 70% of the BM blasts (patients 11 and 25) werc POEM positive (POEM'). Control experiments excluded the possibility of a staining artifact or an adverse effect on peroxidase by cryoprescrvation.
Three different stages of myeloperoxidase expression could be idcntified (Table 1 ): In four patients (patients 10, 20,22, and 26). UMPO reactivity was granular in that it was located in small granules not detectable by light microscopy (GR, Fig 1B) . In two cases (patients 9 and 21), the blasts displayed a "membranous-granular'' reactivity (MG) with peroxidase detectable in the membranous structures (ie, nuclear envelope and endoplasmic reticulum with or without the Golgi complex) together with granular reactivity (Fig 1A) . In another 11 patients, only membranous reactivity (M) could be detected (Fig 2) . Three of these patients (patients 12, 24, and 25). however, proved to be platelet pcroxidase positive (UPPO, Fig 3) . The remaining nine patients had various combinations of the different stages of mycloperoxidasc expression.
POEM positivity was associated with different immunophenotypes (Table 1 ). All but five patients (patients 2.3, 8, 12, and 18) wcre HLA-DR+. Twenty of 26 POEM' patients displayed myeloid surface antigens. either alone (patients 1 through 10) or in combination with the CD7 antigen (patients 11 through 15) or with B-lymphoid surface markers (patients 16 through 20). Four of the remaining six cases had only HLA-Dr and TdT positivity, whereas patient 21 had CD7 and patient 22 had CD24 positivity. Eight of the POEM' patients had immunoglobulin heavy chain gene rearrangements, including an oligoclonal rearrangement pattern in thrce of eight patients, whereas no light chain gene rearrangement was detected.
POEM-patients. Thirty-one of 57 c a w were POEM-, with less than 1% POEM+ blasts in the PB or less than 5% of the BM (Table 2 ). All but two patients (patients 27 and 42) displayed HLA-DR positivity. Twenty-one of 31 POEMpatients had myeloid surface markers, either alone (paticnts 27 through 31) or in combination with the CD7 antigen (patients 32 and 33) or together with B-lymphoid surface markers (patients 34 through 47). In the latter group, 11 patients displayed an overlapping frequency of myeloid and B-lymphoid markers as indirect evidence for cocxprcssion of thcsc specificities. Of the remaining 10 patients, 8 showed only lymphoid markers, whereas 2 patients showed only TdT and HLA-DR positivity (patients 56 and 57). B-Lymphoid surface marker expression closely paralleled Ig heavy chain gene rearrangement, whereas only one of the patients displaying a pure myeloid or a CD7/myeloid phenotypc had an Ig gene rearrangement (patient 27). Again, no Ig light chain gene rearrangement could be dctccted.
Correlation between the phenotype and POEM expression for all 57 patients under study was significant only for the CD19 or CD24 antigen positivity and POEM negativity (P = .001 and P = .023, respectively), whereas no significant correlation for any myeloid marker could be dctccted (data not shown; Fisher's exact test).
Treatment results. The clinical outcome of 29 of the 57 patients could be evaluated. They had been included in an ongoing trial for treatment of ALL and AUL in adults.' For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Table 3 shows the main clinical and hematologic data. Fourteen of the 29 patients were UMPO'. The median age of these patients was higher than that of the 15 UMPOpatients, whereas their median leukocyte count was lower than that of the latter group. The CR rate of all patients after induction therapy was 55%. with a CR rate of 29% in UMPO' patients v a CR rate of 80% in the UMPOpatients (P < .0073). UMPO positivity also had an adverse effect on remission duration, with a median of 5 v 20 months (P < .OO01), and on survival, with a median survival timc of 9 v 28 months (P = .OlB). None of the surface markers nor age nor pretreatment lcukocyte count had a significant association with outcome (data not shown).
major proportion of POEM+ blasts is strongly suggestive of myeloid or megakaryoblastic differentiation of these leukemias. POEM positivity was associated with different immunophenotypcs. Obviously, some discrepancy exists between myeloid antigen expression and ultrastructurallydemonstrable myeloid or mcgakaryoblastic differentiation. The most striking differenccs were noted in peroxidase-positive patients who were surface marker negative. In the two UPPO' patients (patients 24 and 25). however, demonstration of this enzyme might precede antigen expression.u In the other patients, the meaning of thcsc discrepancies, which is in wmc contrast to r a n t reports, is unclear."." This may result from an asynchrony between surface marker expression and cytoplasmic maturation as a result of neoplastic transformation. Regardless of the explanation, these observations call into question the value of the myeloid surface markers and Ig gcnc configuration for detection of myeloid or megakaryoblastic diffcrentiation of AUL cases and underline the potential significance of ultrastructural analysis.
Detection of lymphoid antigens on a major part of POEM+ leukemias remains uncxplained. The malignant
DISCUSSION
In 26 of 57 AUL patients, a significant proportion of blasts were POEM'. In three of these patients cases peroxidase could be identified as platelet peroxidase (UPPO) (patients 12, 24, and 25). whereas the remaining cases expressed myeloperoxidase (UMPO). Because myeloperoxidase and platelet peroxidase are gencrally acccptcd as lineage-specific markers. dctection of a
POEM+potienrs.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From rearrangement; R, rearranged; G, germline; R*, oligoclonal; POEM, denotes ultrastructural demonstration of peroxidase. clone could represent a bipotential progenitor cell that has retained lymphocytic markers during myeloid or megakaryoblastic differentiati~n.'~.'~ This hypothesis is supported by in vitro culture data, which showed that several AUL cases retained their lymphoid antigens after induction of myeloperoxidase by TPA.21,30 The presence of biclonal leukemias, however, cannot be ruled out although the morphologic appearance of the POEM+ and POEM-blasts was similar in all cases. On the other hand, a lack of lineage specificity of these markers or an aberrant marker expression resulting from genetic misprogramming cannot be excluded. The latter view is supported by the preferential association of these phenotypes with certain chromosomal abnormalities, eg, the 1 lq23 trans location^.^^ Further indirect evidence for the myeloid association of these leukemias is provided by the poor response of 14 UMPO' patients after ALL-related chemotherapy. Their low CR rate and the short duration of remission indicate that these patients were refractory to the applied chemotherapy and suggest that they constitute a distinct subgroup.
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From Whether these patients might benefit from a chemotherapy more specific for acute myeloid leukemias is not Our own experience and several previous reports indicate that a more intensified chemotherapy including allogeneic bone marrow transplantation in early remission seems necessary to improve o~t c o m e . ' *~~~'~ The POEM-patients are a very heterogenous group. Some of them probably are very early lymphoblastic leukemias, as indicated by the presence of lymphoid markers and Ig gene rearrangement. The remaining patients may have a type of leukemia in which malignant transformation has affected a progenitor cell before lineage ~ommitment.~.~' Further studies including analysis of myeloperoxidase gene expression and in vitro differentiation induction appear to be necessary to elucidate the lineage affinity and differentiation capacity of these cases.38 Evidence that the POEM-group of leukemias, irrespective of immunologic phenotype, may be related to lymphoid leukemias is provided by the clinical outcome of POEM-patients
POEM-patients.
after ALL-related chemotherapy. The remission rate, remission duration, and the survival time of 15 patients were comparable to that of typical CALLA' or T-cell ALL patients, despite their high leukocyte numbers at initial diagnosis. In addition, a major proportion of these patients had blasts expressing myeloid markers, which has been reported to be an adverse prognostic These findings support our hypothesis that the detection of myeloid antigens is insufficient to establish myeloid or megakaryoblastic differentiation of AUL cases and that ultrastructural demonstration of peroxidase is necessary for this purpose.
